Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A Review of Keratoconus Cross-Linking Treatment Methods

View through CrossRef
Corneal collagen cross-linking (CXL) is a therapeutic intervention that utilizes riboflavin photochemical activation with ultraviolet-A (UV-A) light to induce covalent cross-links within the stromal corneal fibers, effectively increasing corneal biomechanical stability and halting the progressive ectasia. The method was introduced in the late 1990s in Germany at the University of Dresden. The cross-linking method using the Avedro system (Waltham, MA, USA) was approved by the US Food and Drug Administration (FDA) on 18 April 2016, based on three prospective, multicenter, randomized clinical trials for keratoconus and other corneal ectasias. Recent innovations in CXL include a range of new treatment protocols and methods, which have been introduced to further enhance the clinical effectiveness, efficiency, and safety of CXL. These modifications encompass approaches like transepithelial or epithelium-on CXL (TE-CXL or epi-on CXL), accelerated CXL (ACXL), pulsed CXL (PL-CXL), transepithelial iontophoresis-assisted crosslinking (I-CXL), diluted alcohol and iontophoresis-assisted corneal cross-linking (DAI-CXL), slit-lamp CXL, and CXL plus (combined) methods. This review synthesizes findings on currently used modifications of the cross-linking method, the effectiveness, and directions of development of this currently dominant surgical method of treating corneal ectasia. This review concentrates on the long-term follow-up data, based on publications ranging from 1998 up to 2023.
Title: A Review of Keratoconus Cross-Linking Treatment Methods
Description:
Corneal collagen cross-linking (CXL) is a therapeutic intervention that utilizes riboflavin photochemical activation with ultraviolet-A (UV-A) light to induce covalent cross-links within the stromal corneal fibers, effectively increasing corneal biomechanical stability and halting the progressive ectasia.
The method was introduced in the late 1990s in Germany at the University of Dresden.
The cross-linking method using the Avedro system (Waltham, MA, USA) was approved by the US Food and Drug Administration (FDA) on 18 April 2016, based on three prospective, multicenter, randomized clinical trials for keratoconus and other corneal ectasias.
Recent innovations in CXL include a range of new treatment protocols and methods, which have been introduced to further enhance the clinical effectiveness, efficiency, and safety of CXL.
These modifications encompass approaches like transepithelial or epithelium-on CXL (TE-CXL or epi-on CXL), accelerated CXL (ACXL), pulsed CXL (PL-CXL), transepithelial iontophoresis-assisted crosslinking (I-CXL), diluted alcohol and iontophoresis-assisted corneal cross-linking (DAI-CXL), slit-lamp CXL, and CXL plus (combined) methods.
This review synthesizes findings on currently used modifications of the cross-linking method, the effectiveness, and directions of development of this currently dominant surgical method of treating corneal ectasia.
This review concentrates on the long-term follow-up data, based on publications ranging from 1998 up to 2023.

Related Results

Asthma and Keratoconus: An analysis of the risk factors association with the severity of keratoconus
Asthma and Keratoconus: An analysis of the risk factors association with the severity of keratoconus
Abstract Background: A cross-sectional study was undertaken in Australia to explore a wide range of risk factors associated with keratoconus. A questionnaire addressing age...
Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus
Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus
Abstract.Purpose:  To investigate the expression of proteases, proteolytic activity and cytokines in the tear film of people with keratoconus.Methods:  Basal tears from people with...
A predictive model for early diagnosis of keratoconus
A predictive model for early diagnosis of keratoconus
Abstract Background: The diagnosis of keratoconus in the early stages of the disease is necessary to initiate an early treatment of keratoconus. Furthermore to avoid possib...
A predictive model for early diagnosis of keratoconus
A predictive model for early diagnosis of keratoconus
Abstract Background: The diagnosis of keratoconus in the early stages of the disease is necessary to initiate an early treatment of keratoconus. Furthermore, to avoid possi...
Corneal densitometry analysis in patients diagnosed with keratoconus
Corneal densitometry analysis in patients diagnosed with keratoconus
AbstractPurposeThe purpose of this study is to carry out a comparative study of corneal densitometry (COD) using Pentacam HR in two groups of patients. A control group of normal ey...

Back to Top